Evaluation of etest method for determining caspofungin (MK-0991) susceptibilities of 726 clinical isolates of Candida species

Journal of Clinical Microbiology

Volumn 39, Issue 12, 2001, Pages 4387-4389

  Pfaller, M A ^a   Messer, S A ^a   Mills, K ^a   Bolmstrom, A ^a   Jones, R N ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; CASPOFUNGIN; GLUCOSE;

ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA GUILLIERMONDII; CANDIDA KRUSEI; CANDIDA LUSITANIAE; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONTROLLED STUDY; CULTURE MEDIUM; DILUTION; FUNGUS CULTURE; INCUBATION TIME; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; TEMPERATURE;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; CULTURE MEDIA; HUMANS; MICROBIAL SENSITIVITY TESTS; PEPTIDES; PEPTIDES, CYCLIC;

EID: 0035213473     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.39.12.4387-4389.2001     Document Type: Article

References (24)

1. Fluconazole disk diffusion procedure for determining susceptibility of Candida species
2. Quality control limits for broth microdilution susceptibility tests of ten antifungal agents
3. In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)
4. Antifungal susceptibility testing using the Etest: Comparison with the broth macrodilution technique
5. Evaluation of the Etest system versus a microtitre broth method for antifungal susceptibility testing of yeasts against fluconazole and itraconazole
6. Interlaboratory evaluation of Etest method for testing antifungal susceptibilities of pathogenic yeasts to five antifungal agents by using Casitone agar and solidified RPMI 1640 medium with 2% glucose
7. Antifungal agents and susceptibility tests
8. Antibacterial susceptibility tests: Dilution and disk diffusion methods
9. Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: Performance of three different media assessed by using Etest and National Committee for Clinical Laboratory Standards M27-A methodologies
10. Disk diffusion method for determining susceptibilities of Candida spp. to MK-0991
11. Activity of MK-0991 (L-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp.
12. In vitro growthinhibitory activity of pneumocandins L-733,560 and L-743,872 against putatively amphotericin B- and fluconazole-resistant Candida isolates: Influence of assay conditions
13. Antifungal susceptibility testing: Progress and future developments
14. Antifungal susceptibility testing: Technical advances and potential clinical applications
15. Evaluation of the Etest method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media
16. Evaluation of Etest for determining in vitro susceptibility of yeast isolates to amphotericin B
17. In vitro susceptibilities of Candida blood stream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and voriconazole
18. In vitro susceptibility testing of filamentous fungi: Comparison of Etest and reference microdilution methods for determining itraconazole MICs
19. Evaluation of the Etest method for determining voriconazole susceptibilities of 312 clinical isolates of Candida species by using three different agar media
20. Comparison of Etest and broth microdilution methods for antifungal drug susceptibility testing of moulds
21. In vitro activity of a new pneumocandin antifungal, L-743,872, against azole-susceptible and -resistant Candida species
22. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: Enhanced ability to detect amphotericin B-resistant Candida isolates
23. Candida, Cryptococcus, and other yeasts of medical importance